We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Esophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01234428
Recruitment Status : Completed
First Posted : November 4, 2010
Last Update Posted : November 4, 2010
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to determine whether esophageal dysmotility and dilatation is an important complication in the long term follow-up following laparoscopic gastric banding for morbid obesity.

Condition or disease Intervention/treatment
Esophageal Motility Disorders Procedure: Laparoscopic surgery Procedure: gastric banding

Detailed Description:
Using a yearly barium swallow the diameter of the esophagus will be monitored over the period.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 167 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Esophageal Dysmotility Disorders Following Laparoscopic Gastric Banding - An Underestimated Complication.
Study Start Date : June 1998
Primary Completion Date : June 2009
Study Completion Date : March 2010
Arms and Interventions

Arm Intervention/treatment
surgery Procedure: Laparoscopic surgery
Gastric banding
Procedure: gastric banding
laparoscopic gastric banding
Other Name: morbid obesity

Outcome Measures

Primary Outcome Measures :
  1. esophageal dilatation [ Time Frame: yearly follow-up over 12 year period ]
    esophageal dilatation or dysfunction

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • BMI more than 40

Exclusion Criteria:

  • BMI below 40
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01234428

Department of Surgery, Spital STS AG Thun
Thun, Switzerland, 3600
Sponsors and Collaborators
Spital STS AG
Department of Medicine, Spital STS AG Thun
Principal Investigator: Markus Naef, MD, MBA Spital STS AG Thun, Switzerland
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Markus Naef, MD, MBA, Department of Surgery, Spital STS AG Thun, Switzerland
ClinicalTrials.gov Identifier: NCT01234428     History of Changes
Other Study ID Numbers: MOB-12-STS-AG
First Posted: November 4, 2010    Key Record Dates
Last Update Posted: November 4, 2010
Last Verified: November 2010

Keywords provided by Spital STS AG:
adjustable gastric banding
morbid obesity
esophageal motility
esophageal dilatation

Additional relevant MeSH terms:
Esophageal Motility Disorders
Esophageal Spasm, Diffuse
Deglutition Disorders
Esophageal Diseases
Gastrointestinal Diseases
Digestive System Diseases